Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00289315 · ClinicalTrials.gov registry record · NA
The Louisiana (LA) Health Project
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 2,060
- Enrollment target
NCT00289315: Completed NA study, sponsored by Pennington Biomedical Research Center.
NCT00289315 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 2,060 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00289315, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,060 participants
- Enrollment target
Study Summary
There is a worldwide pandemic of obesity with far-reaching consequences for the health of our nation. Obesity is the second leading cause of preventable death in the United States. Prevention of obesity, especially in children, has been deemed by public health policy makers to be one of the most important objectives for our country.
Primary Outcome
change in percent body fat between Baseline and 3 years for boys
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Primary (Environmental) Weight Gain Prevention
- BEHAVIORAL Secondary (Behavioral) Weight Gain Prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,060 participants |
| Start Date | 2005-08 |
| Est. Completion | 2009-05 |
| Phase | NA |
What the finished NCT00289315 record still lists
NCT00289315 is an interventional study that assigns participants to a tested intervention. Its 2,060 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (47% higher).
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT00289315 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00289315 about?
NCT00289315 is a clinical study titled "The Louisiana (LA) Health Project". There is a worldwide pandemic of obesity with far-reaching consequences for the health of our nation. Obesity is the second leading cause of preventable death in the United States. Prevention of obesity, especially in children, has been deemed by public health policy makers to be one of the most imp...
What is the current status of trial NCT00289315?
This trial is currently completed. It is a NA study. The enrollment target is 2,060 participants. The study started on 2005-08. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00289315?
The interventions under investigation include: Control (BEHAVIORAL), Primary (Environmental) Weight Gain Prevention (BEHAVIORAL), Secondary (Behavioral) Weight Gain Prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00289315?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00289315's enrollment target sits among peer trials
2,060 51st of 2000 higher than 1,950 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04871542 · 2,062 participants
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
- NCT06521944 · 2,062 participants
RSV Vaccine Pregnancy Registry
- NCT07168993 · 2,063 participants · NA
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
- NCT06666192 · 2,067 participants · NA
The Ohio State University (OSU) SCREEN Community Program
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia